Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Response to Skinner et al

Br J Haematol. 2019 Sep;186(5):782-783. doi: 10.1111/bjh.15949. Epub 2019 May 8.

Jifang Zhou¹, Jin Han^{1

2

3}, Edith A Nutescu¹, William L Galanter^{2

4}, Surrey M Walton¹, Victor R Gordeuk³, Santosh L Saraf³, Gregory S Calip^{1

5}

¹ Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL, USA.
² Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.
³ Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, Chicago, IL, USA.
⁴ Department of Medicine, Section of Academic Internal Medicine & Geriatrics, University of Illinois at Chicago, Chicago, IL, USA.
⁵ Division of Public Health Sciences, Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

No abstract available

Keywords: diabetes; epidemiology; sickle cell disease.

Publication types